Arm-hand Boost Program During Inpatient Rehabilitation After Stroke
1 other identifier
interventional
20
1 country
1
Brief Summary
A pilot cross-over RCT including participants with sub-acute stroke is conducted in an inpatient rehabilitation setting. The experimental group (EG) receives an arm-hand boost program on top of their usual care program. The control group (CG) receives a dose-matched program of strengthening exercises for the lower limbs and general reconditioning. After 4 weeks, a cross-over is performed. Before, after 4 weeks and after 8 weeks of additional therapy, different clinical outcome measures for the upper limb are administered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2019
CompletedFirst Submitted
Initial submission to the registry
September 4, 2020
CompletedFirst Posted
Study publicly available on registry
October 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2020
CompletedFebruary 11, 2021
August 1, 2020
1.5 years
September 4, 2020
February 10, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Change from Fugl-Meyer Assessment-Upper Extremity at 4 weeks
UL assessment - Function
Between baseline and first 4 weeks of study
Change from Fugl-Meyer Assessment-Upper Extremity at 8 weeks
UL assessment - Function
Between baseline and end of study (=8 weeks)
Change from Action Research Arm Test at 4 weeks
UL Assessment - Activities
Between baseline and first 4 weeks of study
Change from Action Research Arm Test at 8 weeks
UL Assessment - Activities
Between baseline and end of study (=8 weeks)
Secondary Outcomes (8)
Change from Jebsen Taylor hand function test at 4 weeks
Between baseline and first 4 weeks of study
Change from Jebsen Taylor hand function test at 8 weeks
Between baseline and end of study (=8 weeks)
Change from Rivermead Motor Assessment Arm function at 4 weeks
Between baseline and first 4 weeks of study
Change from Rivermead Motor Assessment Arm function at 8 weeks
Between baseline and end of study (=8 weeks)
Change from Stroke upper limb capacity scale (SULCS) at 4 weeks
Between baseline and first 4 weeks of study
- +3 more secondary outcomes
Study Arms (2)
Arm-hand BOOST + Control
EXPERIMENTALFirst 4 weeks arm-hand boost program, afterwards, 4 weeks of control program
Control + Arm-hand BOOST
EXPERIMENTALFirst 4 weeks control program, afterwards 4 weeks arm-hand boost program
Interventions
The arm-hand boost program is provided 1 hour/day, 5x/week for 4 weeks, on top of their usual care program. The focus of the boost program is on scapula-setting, core-stability when reaching, movements with 30-60° flexion/abduction in shoulder, fine manipulation and integration in complex ADL tasks. Additionally, patients exercise 1 hour per week using the Armeo Power (Hocoma). Therefore, the additional arm-hand boost program consists of 24 one-hour sessions, provided over four weeks.
A dose-matched program of strengthening exercises for the lower limbs and general reconditioning
Eligibility Criteria
You may qualify if:
- first stroke, as defined by WHO,
- minimal stay of 4 weeks in inpatient setting at study start
- minimally 18 years old
- being able to sit independently (trunk control test, item 3 = 25),
- motor impairment in the upper limb (Fugl-Meyer assessment, stage 2 (synergies): 8-17p, or stage 2: \<8p combined witht stage 5 (hand): \>6p
- sufficient cooperation to perform intervention and evaluations
You may not qualify if:
- musculoskeletal and/or other neurological impairments with permanent damage that may hinder the study
- subdural hematoma, tumor, encephalitis, trauma, or other that lead to similar symptoms as stroke
- severe communication, cognitive or language impairments that hinder the investigations
- no written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa Hospital, Campus Sint-Ursula
Herk-de-Stad, 3540, Belgium
Related Publications (1)
Meyer S, Verheyden G, Kempeneers K, Michielsen M. Arm-Hand Boost Therapy During Inpatient Stroke Rehabilitation: A Pilot Randomized Controlled Trial. Front Neurol. 2021 Feb 26;12:652042. doi: 10.3389/fneur.2021.652042. eCollection 2021.
PMID: 33716948DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Meyer, PhD
Jessa Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2020
First Posted
October 12, 2020
Study Start
May 9, 2019
Primary Completion
November 3, 2020
Study Completion
November 3, 2020
Last Updated
February 11, 2021
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share